Studies outcomes of peritoneal dialysis catheters placed through the skin
Follows adults with kidney failure who receive a dialysis catheter placed through the skin.
Plain-language title generated from the registry record
Registry title: Percutaneous Peritoneal Dialysis Catheter Insertion (PREDICT)
Key facts
- Where
- Brussels, BelgiumSee the site
Where in Belgium
- Universitair Ziekenhuis BrusselBrussels, BelgiumTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Universitair Ziekenhuis Brussel
- Trial code
- NCT06065982
- Record updated
- 4 October 2023
- Original description
Peritoneal dialysis (PD) is the most frequent modality of home dialysis for patients with kidney failure.Read full original descriptionShow less
Prospective Observational Cohort Study on the Outcomes of Percutaneous Inserted PD Catheters
Peritoneal dialysis (PD) is the most frequent modality of home dialysis for patients with kidney failure.
Most PD catheters are placed using a laparoscopic technique. This approach requires the availability of a qualified surgeon, time in the operating theater and general anaesthesia for the patient. Thus, the laparoscopic technique is less suitable for patients with severe heart failure or multimorbidity where general anaesthesia is not possible.
PD catheters can also be inserted using a percutaneous strategy using a modified Seldinger technique. This strategy can be performed bedside under local anaesthesia, by the nephrologist, radiologist, a surgeon, physician assistant or qualified nurse.
The availability of the percutaneous implantation strategy of a PD catheter in a nephrology center may accomodate more patients to receive a PD catheter insertion, including those who have a contraindication to general anaesthesia or need urgent PD.
The PREDICT project aims to increase knowledge and competencies on percutaneous PD catheter insertions by training centers for this technique. By establisching a prospective registry, the outcomes of percutaneously inserted PD catheters, both in experienced and newly trained centers, will be assessed.
Inclusion: Age > 18 years; Percutaneous PD catheter insertion between March 1st 2023 and March 1st 2026 Patients can be included 4 weeks before until 12 weeks after PD catheter insertion.
Exclusion: Inability to provide informed consent; Life expectancy < 3 months.